No Picture
Los Angeles Biotech News

Troubled Unum rebrands as Cogent Biosciences, replaces CEO Chuck Wilson with Andrew Robbins; Jennifer Fox appointed as CFO at David Hung-led Nuvation Bio

Andrew Robbins
→ Rife with turmoil and hit with a barrage of FDA holds as it spiraled into penny-stock territory, Unum Therapeutics hopes a new name — Cogent Biosciences — and a new CEO can turn its fortunes around. Andrew Robbins takes control now and… […]

No Picture
Los Angeles Biotech News

Two more biotechs price IPOs, bringing total raise to record heights

Atea Pharmaceuticals and SQZ Biotechnologies have priced their public debuts, adding to this year’s record biotech IPO raise — a pot spilling over $13 billion that dwarfs the total raises of the last four years.
Last Friday, Nasdaq head of healthcare l… […]

No Picture
Los Angeles Biotech News

Arcutis Biotherapeutics to Present New Data from ARQ-151 (Topical Roflumilast Cream) Clinical Program at Three Global Dermatology Conferences

WESTLAKE VILLAGE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological di… […]

No Picture
Los Angeles Biotech News

Opiant Pharmaceuticals Partners with Aptar Pharma for Nasal Nalmefene Opioid Overdose Treatment

SANTA MONICA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT) today announced it has entered into an agreement with drug delivery specialist Aptar Pharma (“Aptar”), for the development of OPNT003 nasal… […]

No Picture
Los Angeles Biotech News

NTS’s Multi-Million-Dollar Investment Bolsters Testing Capabilities at World-Class Lab in “Rocket City”

ANAHEIM, Calif.–(BUSINESS WIRE)– #AHigherStandard–NTS, the leader in testing, inspection, and certification solutions in North America, is pleased to announce that its laboratory in Huntsville, AL has expanded its testing capabilities with a multi-m… […]

No Picture
Los Angeles Biotech News

Axonics® Submits PMA Supplement to FDA to Further Expand MRI Labeling

IRVINE, Calif.–(BUSINESS WIRE)–Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel … […]

No Picture
Los Angeles Biotech News

Applied Medical Releases the Next Advancement of Its Voyant® Intelligent Energy System Delivering Impressive Clinical Performance Benefits

RANCHO SANTA MARGARITA, Calif.–(BUSINESS WIRE)–Applied Medical launches the next advancement of its Voyant Intelligent Energy system – a new algorithm to further enhance clinical performance. […]

No Picture
Los Angeles Biotech News

Opiant Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020

SANTA MONICA, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its third quarter… […]

No Picture
Los Angeles Biotech News

Gemelli Biotech Launches Novel Breath Test Measuring Hydrogen, Methane and Hydrogen Sulfide

LOS ANGELES & RALEIGH, N.C.–(BUSINESS WIRE)– #H2S–Los Angeles- and Raleigh-based Gemelli Biotech announced the launch of a novel breath test called trio-smart™ that provides a more complete fermented gas profile of a patient’s microbiome by meas… […]